Additionally, increased FGF21 expression positively correlated with improved overall survival (OS), whereas increased levels of CXCL9 and IL-33 were associated with decreased OS in patients with glioblastoma, although the difference was not statistically significant (Supplementary Figure S5). The gene discussed is FGF21; the disease is glioblastoma.